The Conversation (0)
US Life Sciences Companies Raise More Than $400M Through ATM Offerings
Apr. 08, 2013 07:47PM PST
Company NewsBrinson Patrick Securities Corporation, an investment bank that specializes in at-the-market (ATM) offerings, said that US life sciences companies raised approximately $404 million through ATMs last year, with a 78% increase from the previous year.
Brinson Patrick Securities Corporation, an investment bank that specializes in at-the-market (ATM) offerings, said that US life sciences companies raised approximately $404 million through ATMs last year, with a 78% increase from the previous year.
As quoted in the press release:
In the fourth quarter of 2012, life sciences companies raised $128 million through ATMs, compared to $101 million in the third quarter, a 27 percent increase. This ATM activity included the following companies: StemCells Inc. (NASDAQ: STEM), Newark, Calif.; Sarepta Therapeutics Inc. (NASDAQ: SRPT), Cambridge, Mass.; Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS), San Francisco, Calif.; Acadia Pharmaceuticals Inc. (NASDAQ: ACAD), San Diego, Calif.
Click here to read the full Brinson Patrick Securities Corporation press release.